Localized prostate cancer treated with intensity-modulated radiotherapy

Area of Science:

• Radiation Oncology
• Medical Physics

Background:

• Advanced radiotherapy techniques like 3D conformal radiotherapy and intensity-modulated radiotherapy (IMRT) enable higher radiation doses.
• These techniques aim to improve therapeutic ratios by escalating doses while minimizing toxicity.

Purpose of the Study:

• To evaluate the acute and late toxicity of high-dose (80 Gy) intensity-modulated radiotherapy (IMRT) for prostate cancer.
• To assess the feasibility of integrating IMRT into routine clinical workflow.

Main Methods:

• A cohort of 60 prostate cancer patients received high-dose IMRT (80 Gy) between June 2003 and December 2004.
• Patients included had no clinical or radiographic evidence of distant disease at the start of radiotherapy.

Main Results:

• IMRT treatments were successfully delivered without technical issues or interruptions.
• High-dose IMRT was well-tolerated acutely. Late toxicities included grade 1 rectal toxicity in 10% and grade 1 urinary symptoms in 20% of patients.
• No severe (grade 3) toxicity was observed despite the high delivered dose.

Conclusions:

• IMRT is a suitable method for delivering high-dose radiotherapy for prostate cancer.
• The integration of IMRT into routine practice is feasible with minor adjustments to workflow.
• High-dose IMRT demonstrates a favorable toxicity profile, making it an approach of choice.